Phase 3 IBD Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
ColitisIBD (Inflammatory Bowel Disease)Probiotic Intervention
Changhai Hospital120 enrolled1 locationNCT07047339
Recruiting
Phase 2Phase 3
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Fibroblast Activation Protein InhibitorUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10 enrolled1 locationNCT06604273
Completed
Phase 3Phase 4
Use of Ajunctive Allopurinol in Azathioprine/6-Mercaptopurine Non-responders to Optimize 6-Thioguanine Nucleotide Production and Improve Clinical Outcomes in Patients with Inflammatory Bowel Disease (IBD).
Inflammatory Bowel Disease (IBD)
The Alfred Hospital78 enrolled1 locationACTRN12611000363987